APNAR PHARMA Revenue and Competitors
Estimated Revenue & Valuation
- APNAR PHARMA's estimated annual revenue is currently $20.1M per year.
- APNAR PHARMA's estimated revenue per employee is $231,034
Employee Data
- APNAR PHARMA has 87 Employees.
- APNAR PHARMA grew their employee count by 5% last year.
APNAR PHARMA's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Strategy and Quality Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Managing Director | Reveal Email/Phone |
4 | Director Operations | Reveal Email/Phone |
5 | Sales and Business Development | Reveal Email/Phone |
APNAR PHARMA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 542 | -3% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1634 | -2% | N/A | N/A |
#10 | $10.5M | 48 | 12% | N/A | N/A |
What Is APNAR PHARMA?
Apnar Pharma is a privately owned, rapidly growing pharmaceutical company engaged in the acquisition, licensing, development(ANDA), sales, marketing & distribution of generic pharmaceuticals drugs and OTC (over the counter) non-prescription items for U.S. market. In addition to our strategic partnerships, we have a highly experienced team of professionals that specialize in Analytical development & analysis, formulation development, Regulatory affairs, quality control & quality assurance , Manufacturing ,accounting, marketing, Distribution and finance; who all work together to provide quality medicinal products.
keywords:N/AN/A
Total Funding
87
Number of Employees
$20.1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.6M | 89 | 29% | N/A |
#2 | $3.5M | 110 | N/A | N/A |
#3 | $10.4M | 110 | 21% | N/A |
#4 | $44M | 110 | 2% | N/A |
#5 | $35.4M | 113 | 41% | N/A |